Skip to main content
Clinical Trials/JPRN-UMIN000053977
JPRN-UMIN000053977
Not yet recruiting
未知

Postoperative delirium prevention and analgesic effects of continuous postoperative administration of dexmedetomidine for craniotomy - Delirium prevention and analgesic effect of dexmedetomidine

Shinonoi general hospital0 sites30 target enrollmentApril 1, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Shinonoi general hospital
Enrollment
30
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2024
End Date
March 31, 2027
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Shinonoi general hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • emergency surgery patient Patients with ASA\-PS3 or higher Patients with contraindications to haloperidol, such as Parkinson's disease Patients with renal impairment and contraindication to NSAIDs Patients who are allergic to other drugs used Patients who cannot consent minor

Outcomes

Primary Outcomes

Not specified

Similar Trials